Table of Contents
Chapter 1 Overview of Pulmonary Drug Delivery Systems
    1.1 Definition of Pulmonary Drug Delivery Systems in This Report
    1.2 Commercial Types of Pulmonary Drug Delivery Systems
        1.2.1 Nebulizers 
        1.2.2 Dry Powder Inhaler (DPI) 
        1.2.3 Metered Dose Inhaler (MDI)
    1.3 Downstream Application of Pulmonary Drug Delivery Systems
        1.3.1 COPD 
        1.3.2 Asthma 
        1.3.3 Others
    1.4 Development History of Pulmonary Drug Delivery Systems
    1.5 Market Status and Trend of Pulmonary Drug Delivery Systems 2013-2023
        1.5.1 Global Pulmonary Drug Delivery Systems Market Status and Trend 2013-2023
        1.5.2 Regional Pulmonary Drug Delivery Systems Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Pulmonary Drug Delivery Systems 2013-2017
    2.2 Sales Market of Pulmonary Drug Delivery Systems by Regions
        2.2.1 Sales Volume of Pulmonary Drug Delivery Systems by Regions
        2.2.2 Sales Value of Pulmonary Drug Delivery Systems by Regions
    2.3 Production Market of Pulmonary Drug Delivery Systems by Regions
    2.4 Global Market Forecast of Pulmonary Drug Delivery Systems 2018-2023
        2.4.1 Global Market Forecast of Pulmonary Drug Delivery Systems 2018-2023
        2.4.2 Market Forecast of Pulmonary Drug Delivery Systems by Regions 2018-2023
Chapter 3 Global Market Status and Forecast by Types
    3.1 Sales Volume of Pulmonary Drug Delivery Systems by Types
    3.2 Sales Value of Pulmonary Drug Delivery Systems by Types
    3.3 Market Forecast of Pulmonary Drug Delivery Systems by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Global Sales Volume of Pulmonary Drug Delivery Systems by Downstream Industry
    4.2 Global Market Forecast of Pulmonary Drug Delivery Systems by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
    5.1 North America Pulmonary Drug Delivery Systems Market Status by Countries
        5.1.1 North America Pulmonary Drug Delivery Systems Sales by Countries (2013-2017)
        5.1.2 North America Pulmonary Drug Delivery Systems Revenue by Countries (2013-2017)
        5.1.3 United States Pulmonary Drug Delivery Systems Market Status (2013-2017)
        5.1.4 Canada Pulmonary Drug Delivery Systems Market Status (2013-2017)
        5.1.5 Mexico Pulmonary Drug Delivery Systems Market Status (2013-2017)
    5.2 North America Pulmonary Drug Delivery Systems Market Status by Manufacturers
    5.3 North America Pulmonary Drug Delivery Systems Market Status by Type (2013-2017)
        5.3.1 North America Pulmonary Drug Delivery Systems Sales by Type (2013-2017)
        5.3.2 North America Pulmonary Drug Delivery Systems Revenue by Type (2013-2017)
    5.4 North America Pulmonary Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
    6.1 Europe Pulmonary Drug Delivery Systems Market Status by Countries
        6.1.1 Europe Pulmonary Drug Delivery Systems Sales by Countries (2013-2017)
        6.1.2 Europe Pulmonary Drug Delivery Systems Revenue by Countries (2013-2017)
        6.1.3 Germany Pulmonary Drug Delivery Systems Market Status (2013-2017)
        6.1.4 UK Pulmonary Drug Delivery Systems Market Status (2013-2017)
        6.1.5 France Pulmonary Drug Delivery Systems Market Status (2013-2017)
        6.1.6 Italy Pulmonary Drug Delivery Systems Market Status (2013-2017)
        6.1.7 Russia Pulmonary Drug Delivery Systems Market Status (2013-2017)
        6.1.8 Spain Pulmonary Drug Delivery Systems Market Status (2013-2017)
        6.1.9 Benelux Pulmonary Drug Delivery Systems Market Status (2013-2017)
    6.2 Europe Pulmonary Drug Delivery Systems Market Status by Manufacturers
    6.3 Europe Pulmonary Drug Delivery Systems Market Status by Type (2013-2017)
        6.3.1 Europe Pulmonary Drug Delivery Systems Sales by Type (2013-2017)
        6.3.2 Europe Pulmonary Drug Delivery Systems Revenue by Type (2013-2017)
    6.4 Europe Pulmonary Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
    7.1 Asia Pacific Pulmonary Drug Delivery Systems Market Status by Countries
        7.1.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Countries (2013-2017)
        7.1.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Countries (2013-2017)
        7.1.3 China Pulmonary Drug Delivery Systems Market Status (2013-2017)
        7.1.4 Japan Pulmonary Drug Delivery Systems Market Status (2013-2017)
        7.1.5 India Pulmonary Drug Delivery Systems Market Status (2013-2017)
        7.1.6 Southeast Asia Pulmonary Drug Delivery Systems Market Status (2013-2017)
        7.1.7 Australia Pulmonary Drug Delivery Systems Market Status (2013-2017)
    7.2 Asia Pacific Pulmonary Drug Delivery Systems Market Status by Manufacturers
    7.3 Asia Pacific Pulmonary Drug Delivery Systems Market Status by Type (2013-2017)
        7.3.1 Asia Pacific Pulmonary Drug Delivery Systems Sales by Type (2013-2017)
        7.3.2 Asia Pacific Pulmonary Drug Delivery Systems Revenue by Type (2013-2017)
    7.4 Asia Pacific Pulmonary Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
    8.1 Latin America Pulmonary Drug Delivery Systems Market Status by Countries
        8.1.1 Latin America Pulmonary Drug Delivery Systems Sales by Countries (2013-2017)
        8.1.2 Latin America Pulmonary Drug Delivery Systems Revenue by Countries (2013-2017)
        8.1.3 Brazil Pulmonary Drug Delivery Systems Market Status (2013-2017)
        8.1.4 Argentina Pulmonary Drug Delivery Systems Market Status (2013-2017)
        8.1.5 Colombia Pulmonary Drug Delivery Systems Market Status (2013-2017)
    8.2 Latin America Pulmonary Drug Delivery Systems Market Status by Manufacturers
    8.3 Latin America Pulmonary Drug Delivery Systems Market Status by Type (2013-2017)
        8.3.1 Latin America Pulmonary Drug Delivery Systems Sales by Type (2013-2017)
        8.3.2 Latin America Pulmonary Drug Delivery Systems Revenue by Type (2013-2017)
    8.4 Latin America Pulmonary Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
    9.1 Middle East and Africa Pulmonary Drug Delivery Systems Market Status by Countries
        9.1.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Countries (2013-2017)
        9.1.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Countries (2013-2017)
        9.1.3 Middle East Pulmonary Drug Delivery Systems Market Status (2013-2017)
        9.1.4 Africa Pulmonary Drug Delivery Systems Market Status (2013-2017)
    9.2 Middle East and Africa Pulmonary Drug Delivery Systems Market Status by Manufacturers
    9.3 Middle East and Africa Pulmonary Drug Delivery Systems Market Status by Type (2013-2017)
        9.3.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales by Type (2013-2017)
        9.3.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue by Type (2013-2017)
    9.4 Middle East and Africa Pulmonary Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 10 Market Driving Factor Analysis of Pulmonary Drug Delivery Systems
    10.1 Global Economy Situation and Trend Overview
    10.2 Pulmonary Drug Delivery Systems Downstream Industry Situation and Trend Overview
Chapter 11 Pulmonary Drug Delivery Systems Market Competition Status by Major Manufacturers
    11.1 Production Volume of Pulmonary Drug Delivery Systems by Major Manufacturers
    11.2 Production Value of Pulmonary Drug Delivery Systems by Major Manufacturers
    11.3 Basic Information of Pulmonary Drug Delivery Systems by Major Manufacturers
        11.3.1 Headquarters Location and Established Time of Pulmonary Drug Delivery Systems Major Manufacturer
        11.3.2 Employees and Revenue Level of Pulmonary Drug Delivery Systems Major Manufacturer
    11.4 Market Competition News and Trend
        11.4.1 Merger, Consolidation or Acquisition News
        11.4.2 Investment or Disinvestment News
        11.4.3 New Product Development and Launch
Chapter 12 Pulmonary Drug Delivery Systems Major Manufacturers Introduction and Market Data
    12.1 3M 
        12.1.1 Company profile
        12.1.2 Representative Pulmonary Drug Delivery Systems Product
        12.1.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of 3M 
    12.2 GSK 
        12.2.1 Company profile
        12.2.2 Representative Pulmonary Drug Delivery Systems Product
        12.2.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of GSK 
    12.3 AstraZeneca 
        12.3.1 Company profile
        12.3.2 Representative Pulmonary Drug Delivery Systems Product
        12.3.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of AstraZeneca 
    12.4 Cipla 
        12.4.1 Company profile
        12.4.2 Representative Pulmonary Drug Delivery Systems Product
        12.4.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Cipla 
    12.5 Chiesi 
        12.5.1 Company profile
        12.5.2 Representative Pulmonary Drug Delivery Systems Product
        12.5.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Chiesi 
    12.6 Boehringer Ingelheim 
        12.6.1 Company profile
        12.6.2 Representative Pulmonary Drug Delivery Systems Product
        12.6.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim 
    12.7 Aptar 
        12.7.1 Company profile
        12.7.2 Representative Pulmonary Drug Delivery Systems Product
        12.7.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Aptar 
    12.8 Novartis 
        12.8.1 Company profile
        12.8.2 Representative Pulmonary Drug Delivery Systems Product
        12.8.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Novartis 
    12.9 Philips Respironics 
        12.9.1 Company profile
        12.9.2 Representative Pulmonary Drug Delivery Systems Product
        12.9.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Philips Respironics 
    12.10 Omron Healthcare 
        12.10.1 Company profile
        12.10.2 Representative Pulmonary Drug Delivery Systems Product
        12.10.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Omron Healthcare 
    12.11 PARI 
        12.11.1 Company profile
        12.11.2 Representative Pulmonary Drug Delivery Systems Product
        12.11.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of PARI 
    12.12 Skyepharma 
        12.12.1 Company profile
        12.12.2 Representative Pulmonary Drug Delivery Systems Product
        12.12.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Skyepharma 
    12.13 CareFusion 
        12.13.1 Company profile
        12.13.2 Representative Pulmonary Drug Delivery Systems Product
        12.13.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of CareFusion 
    12.14 Shanghai Huarui 
        12.14.1 Company profile
        12.14.2 Representative Pulmonary Drug Delivery Systems Product
        12.14.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Shanghai Huarui 
    12.15 Taian Character 
        12.15.1 Company profile
        12.15.2 Representative Pulmonary Drug Delivery Systems Product
        12.15.3 Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Taian Character 
    12.16 Chia Tai Tianqing
Chapter 13 Upstream and Downstream Market Analysis of Pulmonary Drug Delivery Systems
    13.1 Industry Chain of Pulmonary Drug Delivery Systems
    13.2 Upstream Market and Representative Companies Analysis
    13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Pulmonary Drug Delivery Systems
    14.1 Cost Structure Analysis of Pulmonary Drug Delivery Systems
    14.2 Raw Materials Cost Analysis of Pulmonary Drug Delivery Systems
    14.3 Labor Cost Analysis of Pulmonary Drug Delivery Systems
    14.4 Manufacturing Expenses Analysis of Pulmonary Drug Delivery Systems
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Reference

Companies Included in Reports: